Appropriateness of alert antibiotics measured by repeated prevalence surveys and impact of direct prescriber interaction and feedback

References

• Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T, et al. World Health Organization Report: current crisis of antibiotic resistance. BioNanoSci. 2019;9(4):778–788.
   Web of Science ®Google Scholar
• de Kraker ME, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66(2):398–407.
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8(10):e1001104.
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Wolkewitz M, Davey PG, et al. The clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2011;55(4):1598–1605.
   PubMed Web of Science ®Google Scholar
• Wolkewitz M, Frank U, Philips G, et al. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow up beyond hospital discharge. J Antimicrob Chemother. 2010;66(2):381–386.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO global strategy for containment of antimicrobial resistance (WHO/CDS/CSR/DRS/2001 2) [updated 2001. [cited 2021 Mar 5]. Available from: https://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf
   Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an Antibiotic -Stewardship Program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–e77.
   PubMed Web of Science ®Google Scholar
• Braykoy NP, Morgan DJ, Schweizer ML, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;12(12):1220–1227.
   Google Scholar
• Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177.
   PubMed Web of Science ®Google Scholar
• Rubin HR, Pronovost P, Diette GB. From a process of care to a measure: the development and testing of a quality indicator. Int J Qual Health Care. 2001;13(6):489–496.
   PubMed Web of Science ®Google Scholar
• Campbell SM, Braspenning J, Hutchinson A, et al. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003;326(7393):816–819.
   PubMed Web of Science ®Google Scholar
• Hermanides HS, Hulscher ME, Schouten JA, et al. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin Infect Dis. 2008;46(5):703–711.
   PubMed Web of Science ®Google Scholar
• Kallen MC, Prins JM. A systematic review of quality indicators for appropriate antibiotics use in hospitalized adult patients. Infect Dis Rep. 2017;9(1):6821.
   PubMed Web of Science ®Google Scholar
• Schouten JA, Hulscher ME, Wollersheim H, et al. Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis. 2005;41(4):450–460.
   PubMed Web of Science ®Google Scholar
• Van den Bosch CM, Geerlings SE, Natsch S, et al. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2015;60(2):281–291.
   PubMed Web of Science ®Google Scholar
• Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6:e619–629.
   PubMed Web of Science ®Google Scholar
• . Confidential feedback report of global point prevalence survey of antimicrobial consumption and resistance of hospital ID:110, 2015. 2016 https://www.global-pps.com/documents/
   Google Scholar
• World Health Organization. World Health Organization model list of essential medicines, 20st list. 2017 march 2021.
   Google Scholar
• World Health Organization World Health Organization model list of essential medicines, 21st list. [cited 2021 March 2019 2021 2021 2021 2021 2021].
   Google Scholar
• Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals-protocol version 5.3, ECDC PPS 2016-2017 updated 4May 2012 . https://www.ecdc.europa.eu/publications-data/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use Available from: .
   Google Scholar
• Gyssens IC, van den Broek PJ, Kullberg BJ, et al. Optimizing antimicrobial therapy: a method for antimicrobial drug use evaluation. J Antimicrob Chemother. 1992;30(5):724–727.
   PubMed Web of Science ®Google Scholar
• Willemsen I, van der Koo T, van Benthem B, et al. Appropriateness of antimicrobial therapy: a multicenter prevalence survey in the Netherlands, 2008-2009. Euro Surveill. 2010;15(46):19715.
   PubMedGoogle Scholar
• Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta(GA): US Department of Health and Human Services, Center for Disease Control and Prevention. (CDC); 2019 5 2 2022. Available from: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html
   Google Scholar
• Fraser GL, Stogsdill P, Dickens JD, et al. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157(15):1689–1694.
   PubMedGoogle Scholar
• Seligman SJ. Reduction in antibiotic costs by restricting use of oral cephalosporin. Am J Med. 1981;71(6):941–944.
   PubMed Web of Science ®Google Scholar
• Britton HL, Schwinghammer TL, Romano MJ. Cost containment through restrictions of cephalosporins. Am J Hosp Pharm. 1981;38(12):1897–1900.
   PubMedGoogle Scholar
• Maswoswe JJ, Okpara AU. Enforcing a policy for restricting antimicrobial drug use. Am J Health Syst Pharm. 1995;52(13):1433–1435.
   PubMed Web of Science ®Google Scholar
• Briceland LL, Nightingale CH, Quintiliani R, et al. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch of Intern Med. 1988;148(9):2019–2022.
   PubMedGoogle Scholar
• McGregor JC, Weekes E, Forrest GN, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc. 2006;13(4):378–384.
   PubMed Web of Science ®Google Scholar
• Gums JG, Yancey RW Jr, Hamilton CA, et al. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999;19(12):1369–1377.
   PubMed Web of Science ®Google Scholar